2007 JASN IMPACT FACTOR 7.111	HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP
advanced	CURRENT ISSUE	ARCHIVES	JASN Express	ONLINE SUBMISSION

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by SUNDIN, D. P. Articles by MOLITORIS, B. A. Search for Related Content PubMed PubMed Citation Articles by SUNDIN, D. P. Articles by MOLITORIS, B. A.

Gentamicin Inhibits Renal Protein and Phospholipid Metabolism in Rats: Implications Involving Intracellular Trafficking

Department of Medicine, Division of Nephrology, Indiana University School of Medicine, and the Roudebush Veterans Affairs Medical Center, Indianapolis, Indiana.

Correspondence to Dr. Bruce A. Molitoris, Indiana University School of Medicine, 1120 South Dr., Fesler Hall, Room 108, Indianapolis, IN 46202. Phone: 317-274-5287; Fax: 317-274-8575; E-mail: bmolitor{at}mdep.iupui.edu

Abstract. Studies were undertaken to characterize the mechanism of aminoglycoside-induced nephrotoxicity. Early time points in gentamicin treatment (1 to 3 d) were used to investigate the development of toxic events without the complication of gross morphologic cellular alterations. Enzyme activities of cortical homogenates and brush border membrane (BBM) preparations documented little effect on specific activities or the ability to isolate representative membrane fractions. In vivo protein synthesis experiments demonstrated that gentamicin reduced cellular protein synthesis after 2 d of treatment. This inhibition increased to 50% on the third day. Total cellular proteins synthesis was inhibited to the same extent as BBM protein synthesis. However, gentamicin had different effects on homogenate versus BBM phospholipids. The total phospholipid contents in cortical homogenates and BBM from treated animals were increased, compared with control animals. A significant decrease in phospholipid synthesis was observed only in homogenates from treated animals. When effects on individual phospholipids were investigated, only an increase in phosphatidylinositol levels was observed in cortical homogenates from treated rats. However, gentamicin treatment was demonstrated to increase the levels of phosphatidylinositol and phosphatidylcholine, while decreasing the level of sphingomyelin (SPH), in BBM. Incorporation of ³²P into SPH, phosphatidylserine, and phosphatidylethanolamine was inhibited in cortical homogenates from gentamicin-treated animals; among BBM phospholipids, however, a significant decrease was observed only for SPH synthesis. It was concluded that inhibition of phospholipid degradation was quantitatively the major contributor to the effects of gentamicin on phospholipid metabolism. Confocal microscopic studies, using tracer amounts of fluorescently labeled gentamicin, revealed gentamicin in large, mostly basal structures. Correlative electron microscopic studies, using photo-oxidation techniques, demonstrated that these structures consisted of lysosomal, Golgi complex, and mitochondrial structures. These observations suggest retrograde trafficking of gentamicin and indicate a general mechanism of gentamicin-induced nephrotoxicity.

This article has been cited by other articles:

				H. Meistermann, J. L. Norris, H.-R. Aerni, D. S. Cornett, A. Friedlein, A. R. Erskine, A. Augustin, M. C. De Vera Mudry, S. Ruepp, L. Suter, et al. Biomarker Discovery by Imaging Mass Spectrometry: Transthyretin is a Biomarker for Gentamicin-induced Nephrotoxicity in Rat Mol. Cell. Proteomics, October 1, 2006; 5(10): 1876 - 1886. [Abstract] [Full Text] [PDF]

				R. M. Sandoval, M. D. Kennedy, P. S. Low, and B. A. Molitoris Uptake and trafficking of fluorescent conjugates of folic acid in intact kidney determined using intravital two-photon microscopy Am J Physiol Cell Physiol, August 1, 2004; 287(2): C517 - C526. [Abstract] [Full Text] [PDF]

				F. W. Ballardie IgA nephropathy treatment 25 years on: can we halt progression? The evidence base Nephrol. Dial. Transplant., May 1, 2004; 19(5): 1041 - 1046. [Full Text] [PDF]

				R. M. Sandoval and B. A. Molitoris Gentamicin traffics retrograde through the secretory pathway and is released in the cytosol via the endoplasmic reticulum Am J Physiol Renal Physiol, April 1, 2004; 286(4): F617 - F624. [Abstract] [Full Text] [PDF]

				K. D. O'Neill, N. X. Chen, M. Wang, R. Cocklin, Y. Zhang, and S. M. Moe Cellular uptake of {beta}2M and AGE-{beta}2M in synovial fibroblasts and macrophages Nephrol. Dial. Transplant., January 1, 2003; 18(1): 46 - 53. [Abstract] [Full Text] [PDF]

				R. M. Sandoval, R. L. Bacallao, K. W. Dunn, J. D. Leiser, and B. A. Molitoris Nucleotide depletion increases trafficking of gentamicin to the Golgi complex in LLC-PK1 cells Am J Physiol Renal Physiol, December 1, 2002; 283(6): F1422 - F1429. [Abstract] [Full Text] [PDF]

				C. Schmitz, J. Hilpert, C. Jacobsen, C. Boensch, E. I. Christensen, F. C. Luft, and T. E. Willnow Megalin Deficiency Offers Protection from Renal Aminoglycoside Accumulation J. Biol. Chem., January 4, 2002; 277(1): 618 - 622. [Abstract] [Full Text]

				R. A. Girton, D. P. Sundin, and M. E. Rosenberg Clusterin protects renal tubular epithelial cells from gentamicin-mediated cytotoxicity Am J Physiol Renal Physiol, April 1, 2002; 282(4): F703 - F709. [Abstract] [Full Text] [PDF]

Copyright © 2008 by the American Society of Nephrology. Online ISSN: 1533-3450 Print ISSN: 1046-6673